Mgc Pharmaceuticals Share Discussion Threads

[beltd] 05/5/2022 09:33

Lol yeah right.

[vaston] 05/5/2022 08:59

After looking all morning for a bargain , I just came across this company. Very tempted. I see a lot of holders here are massively down . Bel looks like a very disgruntled investor who sold. I’ll have this on my close watch list.

[beltd] 05/5/2022 07:51

Lol pesky. You for the hump that my commentary is spot on. You should listen rather than play childish games

[beltd] 05/5/2022 07:48

Looks like the share price has some serious droop. What does the new hard on witch doctor prescribe? I suspect the med heads are selling while the snake oil salesman pump this. Zomer has got his new CFO printing new shares for the witch doctor and to ensure the press is ready for the next dilution.

[red rook] 04/5/2022 21:30

..."MGC Pharmaceuticals enters Indian market through tie-up with HempStreet"
HempStreet will distribute CimetrA and CannEpil, MGC’s cannabis-based formulations for treating Covid-19, in India

...Roby Zomer, co-founder of MGC Pharma, added: "Entry into significant global markets such as India is paramount to MGC Pharma's agenda, advancing phytomedicine adoption globally.
..."India has a long-established and government-supported Ayurvedic healthcare system, and working with HempStreet to facilitate access to our proprietary phytomedicines such as CimetrA and CannEpil and the new formulations on the pipeline, is crucial to gaining a foothold in this market."

[prof_pwhite] 04/5/2022 21:24

And its Sir Heet to you.

[beltd] 04/5/2022 18:35

Heatseek.... You are right, I don't call em verticals wink wink buddy lmao ?

[heatseek77] 04/5/2022 13:10

Should be David G. just got to get the verticals going, don't worry bel'nd and silly billy won't understand what that means

[beltd] 04/5/2022 12:40

I expect shareprophets will be being paid to write a pumping article pre the next dilution. The gravy train chugs on heading to the ever small pot of jam tomorrow on the horizon.We reaffirm our strong sell advice

[beltd] 04/5/2022 12:36

We'll vis a vis this comment "MGC Pharma is leaving its mark in the global medical cannabis industry"..... the only mark left so far is a big skid mark on equity holders wallets. So the strategy now is to do lots partnerships in the hope others will sell MXC products as there is clearly no pull for them. I'm sure like the "partnership" with AMC, Zomer will be giving away equity and also product margin. With already poor margins and an eye watering cash burn, I'd be keen to see the terms of this alleged partnership. Maybe this is why sellers (likely the med heads) always sell on the back of these jam tomorrow announcements

[david gruen] 04/5/2022 11:52

Today's news could be massive for you guys. Expecting a positive ShareProphets write-up!

[ragnarr] 04/5/2022 11:50

https://indianexpress.com/article/cities/gandhinagar/cannabis-meets-ayurveda-at-delhi-based-hempstreet-medicare-7884347/

[ragnarr] 04/5/2022 11:49

https://www.biospectrumindia.com/news/73/21173/hempstreet-partners-with-uk-based-mgc-pharma.html

[heatseek77] 04/5/2022 07:52

Promising

Commenting on the partnership, Abhishek Mohan, Co-founder of HempStreet, said: "We are very excited to work with Roby and the team at MGC Pharma, bringing cutting-edge, scientifically-validated phytopharmaceutical medicines to tackle mass ailments in India and beyond. In particular, CimetrA(TM), which has shown a 100% success rate in Phase II clinical trials in India, will be an important product just on account of the fact that an estimated 15 million individuals are experiencing some sort of Post Covid-19 / Long Covid symptoms.

[cal57] 04/5/2022 07:06

Just need to back up these partnerships now with sales and revenue and the share price will respond.

[sloppyjoe2] 04/5/2022 07:03

More good news... which will also no doubt completely fail to move the share price in the right direction...

[samsung2020] 04/5/2022 06:11

Decent news....HempStreet announces partnership with MGC Pharma to revolutionise Global Phytomedicine Sector4 May 2022ASX, LSE: MXCThe Indian medicinal cannabis solution pioneer and the European biopharma company are combining their R&D and distribution strengths to improve the quality of life.MGC Pharmaceuticals Ltd (' MGC Pharma' or ' the Company '), a European based bio-pharma company specialising in the production and development of phytomedicines, is pleased to announce a partnership with HempStreet, India's first research to retail venture in the medicinal cannabis sector.Headquartered in the UK, MGC Pharma has been working on polyherbal formulations based on cannabis and other phytopharmaceuticals. MGC Pharma has two proprietary formulations CimetrA(TM) and CannEpil(c). CimetrA (TM) is effective in arresting the cytokine storm, a symptom of COVID-19. It is made of natural-sourced ingredients including Artemisinin, Curcumin, and Boswellia serrata. CannEpil (c) is a phytocannabinoid-based medicine that effectively treats drug-resistant Epilepsy. Both products have undergone successful Phase II clinical trials. Through this partnership, and through HempStreet's extensive distribution reach and key institutional partnerships, Indian patients will now have access to these medicines, starting with CimetrA (TM), which had an immediate need as there are currently over 15 million individuals (approximately 30% of all Covid-19 recoverees in India) said to be experiencing some form of post- or long- Covid- 19 related symptoms.The partnership will also accelerate HempStreet's upcoming venture - transdermal delivery technology for cannabinoids - to launch in the markets beyond Asia with the help of MGC Pharma's widespread distribution network in Australia, the UK, Brazil, and Ireland.Commenting on the partnership, Abhishek Mohan, Co-founder of HempStreet, said: "We are very excited to work with Roby and the team at MGC Pharma, bringing cutting-edge, scientifically-validated phytopharmaceutical medicines to tackle mass ailments in India and beyond. In particular, CimetrA(TM), which has shown a 100% success rate in Phase II clinical trials in India, will be an important product just on account of the fact that an estimated 15 million individuals are experiencing some sort of Post Covid-19 / Long Covid symptoms.Further, Roby Zomer, Co-founder, MGC Pharma, said: "Entry into significant global markets such as India is paramount to MGC Pharma's agenda, advancing phytomedicine adoption globally. India has a long-established and government-supported Ayurvedic healthcare system, and working with HempStreet to facilitate access to our proprietary phytomedicines such as CimetrA (TM) and CannEpil (c) and the new formulations on the pipeline, is crucial to gaining a foothold in this market."MGC Pharma is leaving its mark in the global medical cannabis industry by developing and supplying top-quality phytocannabinoid medicines in Europe, North America, and Australasia. This partnership is a significant step for MGC Pharma to tap into the Asian market while helping HempStreet expand its global footprint.Together with MGC Pharma, HempStreet is committed to bring well-researched, highly efficient, and responsibly-dispensed phytomedicines to tackle mass ailments faced by people worldwide. With this partnership, HempStreet aims to combine the R&D and distribution strengths of both companies to improve the quality of life for hundreds of millions of people.

[heatseek77] 03/5/2022 08:28

Just got an email ArtemiC support 20% off 👍

[beltd] 30/4/2022 07:47

A pretty poor sales performance with a jam tomorrow sales outlook once again....Q3 FY22 produced sales of $625K, the majority of sales coming from the phytocannabinoid portfolio and the core Australian market, without any material ArtemiC(TM) sales in the quarter.Note Zomer can't even crow about record sales. Operating costs outstripping sales with increases in administration, research etc all leading to significant cash burn with Zomer now tapping into his credit facilities. All looks like some cheap equity printing on the horizon.Costs increasing, debt increasing, debt servicing costs increasing..... its going to take some remarkable turnaround in sales to stop this going under. How long will equity holders play ball? Good luck you'll need it

[a_2_b] 29/4/2022 17:14

Good news today

[red rook] 29/4/2022 15:55

MGC Pharmaceuticals' CEO explains the latest numbers from the cannabinoid specialist